Reporting to the CSO, Dr. Dao currently leads the CAR/dCas9 cell engineering pre-clinical development for leukemia and solid tumors. Prior to joining Refuge Bio, she served as Director of Immune Cell Therapy for iPSC-CAR T cell program at FujiFilm/Cellular Dynamics International, Senior Program Lead of Allogeneic TCR-T cell program at Immatics, and Assistant Research Professor leading preclinical to IND filing of AML CAR T cell program at City of Hope. She has more than 20 years of cellular engineering experience and has published more than 10 first author peer-reviewed manuscripts in gene therapy and cell therapy. Dr. Dao obtained her B.S. from UCLA and a Ph.D. from USC. She received her stem cell and immunology training at the University of Minnesota and the Institute of Genetique Moleculaire de Medicine in Montpellier, France.